Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model - Wikidata - wikimedia - TriplyDB

Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model

Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model

http://www.wikidata.org/entity/Q33414714

about

RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.Tumor associated macrophages and neutrophils in tumor progression.Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.Bone marrow macrophages support prostate cancer growth in bone.The multifaceted actions of PTHrP in skeletal metastasis The significance of macrophage phenotype in cancer and biomaterials.Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.Cancer and inflammation: implications for pharmacology and therapeutics.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.The chemokine system and cancer.In vivo animal models of spinal metastasis.Microenvironmental Effects of Cell Death in Malignant Disease.A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis.Macrophages, Neutrophils, and Cancer: A Double Edged Sword

P2860

Q24608385-D68CE403-20DF-41F3-AF54-4F1F74D33C82 Q26830743-6C9BCC8D-9E8B-4E89-A5CE-8857ED660A4D Q27317157-CD048556-062F-43AD-891F-F35AEB351BC5 Q28071705-1865755F-9424-4704-BAE1-0E2F0440F901 Q30465097-AAC86D33-70E0-4B8C-AF28-3252FADB0BC2 Q33415914-CA04C509-5390-4A17-AAC7-CB96F15BDFBE Q34306107-547621BA-9AE8-45BE-B525-CC48F1D33F0B Q35598954-9C74C404-1C1C-440F-AFAB-12A596D1DAC9 Q35677936-E382A01B-EFF6-4AB4-A552-920D7125688B Q36546464-B24396FF-5B44-45FA-8566-22E39D389509 Q36593285-8B232B6F-BD09-4473-9E5B-CD4ACA4CFCE2 Q36944484-EAF4E656-DC39-4457-9D26-78A4710F6530 Q37237676-ED8DA4A0-16BE-4D1C-B59F-D3CFCB9BB2C2 Q37594369-8F523DFA-8F20-4DAB-B0AC-F95BDE24D763 Q37702085-8B8A662C-B659-4FE1-B98A-2D617F2272DD Q37901025-768E712F-7404-4749-BA88-612854D7D9AA Q37944479-316E15F2-52DC-4C96-B17E-1A5A96627090 Q37957022-84905FEF-615D-4D2E-A730-9C94EBA5FB51 Q38936695-FD2C6CFA-6F5F-4C8C-B9E3-E6DD14236C1F Q39362628-372C57CF-30D1-41CC-8A8E-D7F94ED959E3 Q55364968-6EC362F8-CB1A-4710-8792-FFAB95179E59 Q55477815-CE6380E0-C245-4BF4-8100-B519FBAFFAF6 Q56942176-20B297B8-F71D-4DB8-96C9-A145369E7C50

P2860

Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model

http://www.wikidata.org/entity/Q33414714

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@ast

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@en

type

label

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@ast

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@en

prefLabel

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@ast

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@en

P1433

Q33414714-F19B6898-3BE8-4071-ADFD-25E6E7978FEC

P1476

Q33414714-52C0A8A6-ED66-4ED8-BC3F-E1B273AB804B

P2093

Q33414714-15EB3A65-FE7D-4B73-8938-0315DAC60B6F

Q33414714-37FFF2B9-1BC4-49A0-ABB8-F12E33CCCCAA

Q33414714-6D8948A8-BC4E-4E48-B6B8-DAF7BB9AD5C6

Q33414714-7E6D78E9-DBF3-43A0-941B-EDE37A0A0AC8

Q33414714-8B62839C-6C08-4937-87AE-8FF7B5FCC732

Q33414714-9CFEEC7E-46DF-4BAB-9D28-5B6E606BF780

Q33414714-B6D3BF9B-038D-4EE2-98FE-1CA27E712B36

Q33414714-CD70FBC2-4C39-4EF3-ACBE-272C7F829355

P2860

Q33414714-01F9EFDE-C0AA-4779-BF47-4F5324DA4795

Q33414714-031BF6CF-2B25-40C3-AB55-2383CAE91587

Q33414714-13D2EE3A-FEC8-4A9A-913C-F3E29048D97B

Q33414714-181D1A3F-29E4-4E33-A0E4-57339CEADE3D

Q33414714-1E7F3563-028C-4455-B2E9-A402BB90486C

Q33414714-214850D2-D1D2-435D-8678-498F539EB848

Q33414714-21709B83-B911-44B6-9588-FC469EC030D1

Q33414714-270C4041-C9B3-4EB0-946A-5AD568C52EA2

Q33414714-3DD21CE6-01E4-4CCC-9078-045B77AEE69D

Q33414714-40B987E8-4C54-4F4C-AA3F-12AD6E16750D

P304

Q33414714-8ADB76BC-02B1-4820-9AF7-DA033272CEAF

P31

Q33414714-735BFC70-18A8-402D-8701-D95388B2EF68

P356

Q33414714-33003759-11CB-43E7-8BC1-E63433F4303A

P433

Q33414714-153754AC-9785-43D1-9941-0E176EE5E951

P478

Q33414714-4DEF63E5-843E-46DA-B02C-77D3AA1BD7B3

P50

Q33414714-30F91B10-F1B8-4781-A622-75D42A0A09B1

Q33414714-C2BA83C2-A405-40AA-916B-1529C802384A

Q33414714-C6B9E870-AB41-44AE-BB4C-2833E55B349D

P577

Q33414714-0675A2F7-2059-4D47-B363-382F0985ABE4

P5875

Q33414714-7F9196C4-05E3-4F5B-9678-A7D0831D7650

P698

Q33414714-E6147555-9F20-4DFC-98DD-7C3B08501F90

P932

Q33414714-0B97717B-72DA-4C8F-98ED-D1257656FF1D

P356

P1433

Journal of Cellular Biochemistry

P1476

Synergy between anti-CCL2 and ...... a metastatic bone cancer model

@en

P2093

Alnawaz Rehemtulla

http://www.w3.org/2001/XMLSchema#string

Brian D Ross

http://www.w3.org/2001/XMLSchema#string

Chris Neeley

http://www.w3.org/2001/XMLSchema#string

Craig J Galbán

http://www.w3.org/2001/XMLSchema#string

Kuei C Lee

http://www.w3.org/2001/XMLSchema#string

Linda A Snyder

http://www.w3.org/2001/XMLSchema#string

Stefan Rozel

http://www.w3.org/2001/XMLSchema#string

Sudha Sud

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.

P304

58-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.22056

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth J. Pienta

Thomas L Chenevert

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24176062

http://www.w3.org/2001/XMLSchema#string

P698

19259948

http://www.w3.org/2001/XMLSchema#string

P932

4293017

http://www.w3.org/2001/XMLSchema#string